Literature DB >> 21376708

Effects of erythropoietin on intracellular calcium concentration of rat primary cortical neurons.

Tomio Andoh1, Noriyuki Echigo, Yoshinori Kamiya, Michiko Hayashi, Ichidai Kudoh, Takahisa Goto.   

Abstract

Erythropoietin (Epo) has been shown to afford neuroprotection in many experimental models. Although the cytosolic Ca(2+) concentration ([Ca(2+)](i)) is an important factor regulating cell survival, the effects of Epo on [Ca(2+)](i) in neurons are not fully elucidated. We studied the effects of human recombinant Epo on [Ca(2+)](i) of rat primary cortical neurons in normal and excitotoxic conditions. Changes in [Ca(2+)](i) were measured using fura-2 microfluorometry in rat primary cortical cultures. In the control condition with 2mM Mg(2+) in the bath solution, Epo at 4 u/ml significantly increased the fluorescence ratio, but the Epo-induced increase in the fluorescence ratio was abolished by omission of Ca(2+) from the bath solution and by the addition of cadmium. Omission of Mg(2+) and supplementation with glycine resulted in basal and periodic increases in the fluorescence ratio, due to sustained activation of N-methyl-d-asparate (NMDA) receptors. Epo at 0.4 and 4 u/ml significantly decreased the fluorescence ratio in this condition, and this effect was attenuated by the phosphoinositide 3-kinase (PI3K) inhibitors, LY 294002 and wortmannin, and the Ca-activated K channel blocker, iberiotoxin. In the presence of Mg(2+) and exogenous glutamate, 4 but not 0.4 u/ml Epo slightly but significantly reduced the [Ca(2+)](i) elevation. These results suggest that Epo increased [Ca(2+)](i) in cortical neurons by inducing Ca(2+) entry in the control condition but decreased [Ca(2+)](i) in the Mg(2+)-free excitotoxic condition, at least in part via PI3K-dependent activation of Ca-activated K channels. Reduction of [Ca(2+)](i) by Epo in the excitotoxic condition may contribute to neuroprotection.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21376708     DOI: 10.1016/j.brainres.2011.02.077

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  6 in total

Review 1.  Unravelling the potential neuroprotective facets of erythropoietin for the treatment of Alzheimer's disease.

Authors:  Dapinder Kaur; Tapan Behl; Aayush Sehgal; Sukhbir Singh; Neelam Sharma; Vishnu Nayak Badavath; Syed Shams Ul Hassan; Mohammad Mehedi Hasan; Saurabh Bhatia; Ahmed Al-Harassi; Haroon Khan; Simona Bungau
Journal:  Metab Brain Dis       Date:  2021-08-26       Impact factor: 3.584

2.  Neuroprotective effect of erythropoietin against pressure ulcer in a mouse model of small fiber neuropathy.

Authors:  Aurore Danigo; Laurent Magy; Laurence Richard; Alexis Desmoulière; Sylvie Bourthoumieu; Benoît Funalot; Claire Demiot
Journal:  PLoS One       Date:  2014-11-25       Impact factor: 3.240

3.  Neuroprotective Effects of neuroEPO Using an In Vitro Model of Stroke.

Authors:  Garzón Fernando; Rodríguez Yamila; García Julio Cesar; Rama Ramón
Journal:  Behav Sci (Basel)       Date:  2018-02-13

4.  Neuroprotective effects of EpoL against oxidative stress induced by soluble oligomers of Aβ peptide.

Authors:  C Castillo; C Fernández-Mendívil; I Buendia; P Saavedra; C Meza; N C Parra; M G Lopez; J R Toledo; J Fuentealba
Journal:  Redox Biol       Date:  2019-04-02       Impact factor: 11.799

5.  Ramipril Alleviates Oxaliplatin-Induced Acute Pain Syndrome in Mice.

Authors:  Hichem Bouchenaki; Aurore Danigo; Amandine Bernard; Flavien Bessaguet; Laurence Richard; Franck Sturtz; David Balayssac; Laurent Magy; Claire Demiot
Journal:  Front Pharmacol       Date:  2021-07-19       Impact factor: 5.810

6.  Erythropoietin alleviates hepatic insulin resistance via PPARγ-dependent AKT activation.

Authors:  Zhijuan Ge; Pengzi Zhang; Ting Hong; Sunyinyan Tang; Ran Meng; Yan Bi; Dalong Zhu
Journal:  Sci Rep       Date:  2015-12-08       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.